📣 VC round data is live. Check it out!

iFLYHealth Valuation Multiples

Discover revenue and EBITDA valuation multiples for iFLYHealth and similar public comparables like Optasia, Indegene, Beijing Haitian Ruisheng, Extreme Vision and more.

iFLYHealth Overview

About iFLYHealth

Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, as well as treatment effect evaluation, to post-discharge management and chronic disease management. It has independently developed AI technologies that underpin its products and solutions. Smart Healthcare, Smart Hospital, Intelligent Hardware, Smart Medical Insurance, and Smart Imaging Union. The Company’s revenue was mainly derived from PHC services and patient services.


Founded

2021

HQ

China

Employees

911

Financials (LTM)

Revenue: $150M
EBITDA: ($5M)

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

iFLYHealth Financials

iFLYHealth reported last 12-month revenue of $150M and negative EBITDA of ($5M).

In the same LTM period, iFLYHealth generated $78M in gross profit, ($5M) in EBITDA losses, and had net loss of ($7M).

Revenue (LTM)


iFLYHealth P&L

In the most recent fiscal year, iFLYHealth reported revenue of $135M and EBITDA of ($5M).

iFLYHealth is unprofitable as of last fiscal year, with gross margin of 50%, EBITDA margin of (4%), and net margin of (7%).

See analyst estimates for iFLYHealth
LTMLast FY202320242025202620272028
Revenue$150M$135M$82M$108M$135M
Gross Profit$78M$68M$47M$60M$68M
Gross Margin52%50%57%55%50%
EBITDA($5M)($5M)($21M)($17M)($5M)
EBITDA Margin(4%)(4%)(26%)(16%)(4%)
EBIT Margin(6%)(7%)(34%)(22%)(7%)
Net Profit($7M)($9M)($23M)($20M)($10M)
Net Margin(5%)(7%)(28%)(18%)(7%)
Net Debt-$23M---

Financial data powered by Morningstar, Inc.

iFLYHealth Stock Performance

iFLYHealth has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


iFLYHealth's stock price is $10.46.

iFLYHealth share price decreased by 0.6% in the last 30 days, and by 21.6% in the last year.

iFLYHealth has an EPS (earnings per share) of $-0.08.

See more trading valuation data for iFLYHealth
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-2.2%-0.6%25.4%-21.6%$-0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

iFLYHealth Valuation Multiples

iFLYHealth trades at 8.3x EV/Revenue multiple, and (233.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for iFLYHealth

EV / Revenue (LTM)


iFLYHealth Financial Valuation Multiples

As of June 4, 2026, iFLYHealth has market cap of $1B and EV of $1B.

iFLYHealth has a P/E ratio of (178.4x).

LTMLast FY202320242025202620272028
EV/Revenue8.3x9.3x15.2x11.5x9.3x
EV/EBITDA(233.9x)(240.0x)(58.9x)(71.8x)(240.0x)
EV/EBIT(131.5x)(134.1x)(45.0x)(53.2x)(134.1x)
EV/Gross Profit16.0x18.4x26.9x21.0x18.4x
P/E(178.4x)(134.9x)(55.4x)(64.5x)(132.0x)
EV/FCFn/m(71.5x)(24.2x)(50.7x)(54.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified iFLYHealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

iFLYHealth Margins & Growth Rates

iFLYHealth grew revenue by 29% but EBITDA decreased by 123% in the last fiscal year.

In the most recent fiscal year, iFLYHealth reported gross margin of 50%, EBITDA margin of (4%), and net margin of (7%).

See estimated margins and future growth rates for iFLYHealth

iFLYHealth Margins

Last FY202420252026202720282029
Gross Margin50%55%50%54%
EBITDA Margin(4%)(16%)(4%)1%
EBIT Margin(7%)(22%)(7%)(3%)
Net Margin(7%)(18%)(7%)(2%)
FCF Margin(13%)(23%)(17%)9%

iFLYHealth Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth29%32%25%29%
Gross Profit Growth38%28%14%38%
EBITDA Growth(123%)(18%)(70%)(123%)
EBIT Growth(46%)(16%)(60%)(46%)
Net Profit Growth(58%)(14%)(51%)(59%)
FCF Growth(194%)(52%)(6%)(171%)

Data powered by FactSet, Inc. and Morningstar, Inc.

iFLYHealth Operational KPIs

iFLYHealth's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

iFLYHealth's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

iFLYHealth's Rule of X is 73% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for iFLYHealth
LTMLast FY202320242025202620272028
Rule of 4027%30%---
Bessemer Rule of X72%73%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue22%23%15%26%23%
G&A Expenses to Revenue11%11%3%13%11%
R&D Expenses to Revenue27%27%47%37%27%
Opex to Revenue-57%90%77%57%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

iFLYHealth Competitors

iFLYHealth competitors include Optasia, Indegene, Beijing Haitian Ruisheng, Extreme Vision, Rackspace, Vitec Software, Rezolve AI, Schrödinger, Arcs Co and Sphere.

Most iFLYHealth public comparables operate across Artificial Intelligence, Healthcare Software, Vertical AI Applications, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Optasia4.9x-16.5x-
Indegene3.1x3.0x16.6x17.0x
Beijing Haitian Ruisheng20.5x17.5x233.4x-
Extreme Vision31.1x27.0x(223.9x)-
Rackspace1.7x1.7x18.2x16.3x
Vitec Software3.6x3.5x9.2x9.5x
Rezolve AI25.3x6.8x(20.2x)(27.9x)
Schrödinger3.2x3.3x(5.9x)(5.9x)

This data is available for Pro users. Sign up to see all iFLYHealth competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About iFLYHealth

When was iFLYHealth founded?iFLYHealth was founded in 2021.
Where is iFLYHealth headquartered?iFLYHealth is headquartered in China.
How many employees does iFLYHealth have?As of today, iFLYHealth has over 911 employees.
Is iFLYHealth publicly listed?Yes, iFLYHealth is a public company listed on HKEX.
What is the stock symbol of iFLYHealth?iFLYHealth trades under 02506 ticker.
When did iFLYHealth go public?iFLYHealth went public in 2024.
Who are competitors of iFLYHealth?iFLYHealth main competitors include Optasia, Indegene, Beijing Haitian Ruisheng, Extreme Vision, Rackspace, Vitec Software, Rezolve AI, Schrödinger, Arcs Co, Sphere.
What is the current market cap of iFLYHealth?iFLYHealth's current market cap is $1B.
What is the current revenue of iFLYHealth?iFLYHealth's last 12 months revenue is $150M.
What is the current revenue growth of iFLYHealth?iFLYHealth revenue growth (NTM/LTM) is 30%.
What is the current EV/Revenue multiple of iFLYHealth?Current revenue multiple of iFLYHealth is 8.3x.
Is iFLYHealth profitable?No, iFLYHealth is not profitable.
What is the current EBITDA of iFLYHealth?iFLYHealth has negative EBITDA and is not profitable.
What is iFLYHealth's EBITDA margin?iFLYHealth's last 12 months EBITDA margin is (4%).
What is the current EV/EBITDA multiple of iFLYHealth?Current EBITDA multiple of iFLYHealth is (233.9x).
What is the current FCF of iFLYHealth?iFLYHealth's last 12 months FCF is ($3M).
What is iFLYHealth's FCF margin?iFLYHealth's last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of iFLYHealth?Current FCF multiple of iFLYHealth is (392.2x).
How many companies iFLYHealth has acquired to date?iFLYHealth hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies iFLYHealth has invested to date?iFLYHealth hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to iFLYHealth

Lists including iFLYHealth

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial